PC
OLMA icon

Pier Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Pier Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Sell
136,108
-3,993
-3% -$88.9K 0.33% 94
2025
Q4 		$3.5M Sell
140,101
-384,148
-73% -$6.84M 0.56% 86
2025
Q3 		$5.13M Sell
524,249
-246,823
-32% -$1.48M 0.8% 63
2025
Q2 		$3.28M Sell
771,072
-46,889
-6% -$209K 0.5% 87
2025
Q1 		$3.08M Buy
817,961
+545,589
+200% +$2.74M 0.52% 85
2024
Q4 		$1.59M Buy
+272,372
New +$2.72M 0.23% 87

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Pier Capital's OLMA Position: Q1 2026 in Review

Pier Capital reduced its Olema Pharmaceuticals (OLMA) stake by 2.9% in Q1 2026, selling an estimated $88.9K and leaving 136,108 shares worth $2.03M. The position accounts for 0.33% of the portfolio, ranked #94.

Pier Capital first reported a position in OLMA in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.13M in Q3 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Pier Capital held 136,108 shares of Olema Pharmaceuticals worth $2.03M as of Q1 2026.
  • Pier Capital sold 3,993 Olema Pharmaceuticals shares in Q1 2026, an estimated $88.9K.
  • Olema Pharmaceuticals made up 0.33% of Pier Capital's portfolio in Q1 2026, its #94 holding.
  • Pier Capital first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Pier Capital's Olema Pharmaceuticals position peaked at $5.13M in Q3 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Pier Capital's 13F filing for Q1 2026, filed 14 May 2026.